biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Mid-May is Monday:

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon May 12, 2023 2:44pm

370 Views

Post# 35445998

Mid-May is Monday:

A Friday after the close press release could be doomday given BTI's cash was expected to last until mid-May. BTI tweets:

@BioasisUS

2h

 		 May is #BrainTumorAwarenessMonth, and it's an important time to show support for all those affected by brain cancers. Let's use this month to raise awareness, educate others, and show compassion for those living with brain cancer.

@BioasisUS

2h

 			 May is #BrainTumorAwarenessMonth, and it's an important time to show support for all those affected by brain cancers. Let's use this month to raise awareness, educate others, and show compassion for those living with brain cancer.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market